More Patients and Doctors Believe in It: Reimbursement of Diabetes Medications Like Ozempic Hits a New Record.
4 Articles
4 Articles
122 million euros: in 2025, the health insurance system in our country (RIZIV) will once again have reimbursed a record amount for diabetes medication such as Ozempic or Mounjaro. This is reported by De Tijd. Specialized doctors are not surprised: diabetes simply continues to be on the rise. "And there are no other medications that work as well against it."
Last year, nearly 130,000 patients received a reimbursement for diabetes medicines, also very popular as weight loss products, write Friday L'Echo and De Tijd, on the basis of new figures published by the National Institute of Sickness and Disability Insurance (Inami). ...
Last year, nearly 130,000 patients received a refund for diabetes medicines, also very popular as weight loss products. The post Still more reimbursement of diabetes treatments in Belgium, they almost quadrupled since 2019 appeared first on Le Vif.
Last year, nearly 130,000 patients were reimbursed for diabetes medicines, which were also very popular as weight loss products. In 2025, more than 128,750 patients were reimbursed for the use of GLP-1-based medicines, of which the Ozempic of the Danish Novo Nordisk laboratory is the most well-known example. Compared to 2019, when the first medicines of this type appeared on the Belgian market, the number of patients treated almost quadrupled. H…
Coverage Details
Bias Distribution
- 100% of the sources are Center
Factuality
To view factuality data please Upgrade to Premium
